Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Utility of normal tissue-to-tumor α/β ratio when evaluating isodoses of isoeffective radiation therapy treatment plans.

Gay HA, Jin JY, Chang AJ, Ten Haken RK.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e81-7. doi: 10.1016/j.ijrobp.2012.09.021. Epub 2012 Nov 7.

PMID:
23141886
2.

Modeling late effects in hypofractionated stereotactic radiotherapy.

Hoban PW, Jones LC, Clark BG.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):199-210.

PMID:
9989527
3.

The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.

Sminia P, Schneider CJ, Fowler JF.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):844-9.

PMID:
11849810
4.

Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers.

Mohan R, Wu Q, Manning M, Schmidt-Ullrich R.

Int J Radiat Oncol Biol Phys. 2000 Feb 1;46(3):619-30.

PMID:
10701741
5.

A challenge to traditional radiation oncology.

Fowler JF, Tomé WA, Fenwick JD, Mehta MP.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1241-56. Erratum in: Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):962. Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):233.

PMID:
15519797
6.

On using the linear-quadratic model in daily clinical practice.

Yaes RJ, Patel P, Maruyama Y.

Int J Radiat Oncol Biol Phys. 1991 Jun;20(6):1353-62.

PMID:
2045309
7.

A mathematical study to select fractionation regimen based on physical dose distribution and the linear-quadratic model.

Mizuta M, Takao S, Date H, Kishimoto N, Sutherland KL, Onimaru R, Shirato H.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):829-33. doi: 10.1016/j.ijrobp.2012.01.004. Epub 2012 Mar 13.

PMID:
22417807
8.

Isodose-based methodology for minimizing the morbidity and mortality of thoracic hypofractionated radiotherapy.

Gay HA, Sibata CH, Allison RR, Jeremic B.

Radiother Oncol. 2009 Jun;91(3):369-78. doi: 10.1016/j.radonc.2008.07.032. Epub 2008 Dec 6. Review.

PMID:
19058867
9.

Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.

Otsuka S, Shibamoto Y, Iwata H, Murata R, Sugie C, Ito M, Ogino H.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1538-43. doi: 10.1016/j.ijrobp.2011.05.034.

PMID:
22115556
10.

Optimizing normal tissue sparing in ion therapy using calculated isoeffective dose for ion selection.

Remmes NB, Herman MG, Kruse JJ.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):756-62. doi: 10.1016/j.ijrobp.2011.08.006. Epub 2012 Mar 19.

PMID:
22436796
11.

Estimation of optimum dose per fraction for high LET radiations: implications for proton radiotherapy.

Jones B, Dale RG.

Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1549-57.

PMID:
11121661
12.

Effect of fractionation in stereotactic body radiation therapy using the linear quadratic model.

Yang J, Lamond J, Fowler J, Lanciano R, Feng J, Brady L.

Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):150-6. doi: 10.1016/j.ijrobp.2012.10.024. Epub 2012 Dec 11.

PMID:
23245283
13.

Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique.

Fuss M, Hug EB, Schaefer RA, Nevinny-Stickel M, Miller DW, Slater JM, Slater JD.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1117-26.

PMID:
10613303
14.

Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints.

Lang S, Kirisits C, Dimopoulos J, Georg D, Pötter R.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):619-27.

PMID:
17869676
15.

Hypofractionation regimens for stereotactic radiotherapy for large brain tumors.

Yuan J, Wang JZ, Lo S, Grecula JC, Ammirati M, Montebello JF, Zhang H, Gupta N, Yuh WT, Mayr NA.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):390-7. doi: 10.1016/j.ijrobp.2007.12.039. Epub 2008 Apr 18.

PMID:
18374501
16.

What hypofractionated protocols should be tested for prostate cancer?

Fowler JF, Ritter MA, Chappell RJ, Brenner DJ.

Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1093-104.

PMID:
12829147
17.

A simple method of obtaining equivalent doses for use in HDR brachytherapy.

Nag S, Gupta N.

Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):507-13.

PMID:
10661360
18.

The impact of fractionation in SBRT: analysis with the linear quadratic model and the universal survival curve model.

Wennberg B, Lax I.

Acta Oncol. 2013 Jun;52(5):902-9. doi: 10.3109/0284186X.2012.728292. Epub 2013 Jan 17.

PMID:
23327339
19.

A feasibility study: Selection of a personalized radiotherapy fractionation schedule using spatiotemporal optimization.

Kim M, Stewart RD, Phillips MH.

Med Phys. 2015 Nov;42(11):6671-8. doi: 10.1118/1.4934369.

PMID:
26520757
20.

Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.

Wang CJ, Huang EY, Sun LM, Chen HC, Fang FM, Hsu HC, Changchien CC, Leung SW.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):179-89.

PMID:
15093915

Supplemental Content

Support Center